Establishment Labs Holdings Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
G31249108
SEDOL
BYVR2D4
CIK
0001688757
www.establishmentlabs.com
LEI:
©
Establishment Labs is a Member of Themefolio
          Hindenburg (TTF)          
FIGI: BBG00X1PG636
ESTA
Establishment Labs Holdings Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Medical Devices
AI
PROFILER
NAME
Establishment Labs Holdings Inc.
ISIN
VGG312491084
TICKER
ESTA
MIC
XNAS
REUTERS
ESTA.OQ
BLOOMBERG
ESTA US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 11.11.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in three upcoming investment conferences. Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chi...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
Thu, 07.11.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of ...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
Thu, 07.11.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2024. Third Quarter Highlights and Outlook Third quarter worldwide revenue of $4...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
Thu, 31.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of three-year clinical results with Mia Femtech™ at the 9th Annual World Symposium on Ergonomic Implants (WSEI) being held this week...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
Thu, 24.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024, and will host a confer...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
Tue, 15.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that it has published its 2024 Post Market Surveillance (PMS) Report. “It is fitting that as we publish our 2024 PMS report, we begin broadly shippi...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
Wed, 02.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today that the first patients in the United States have successfully undergone breast augmentation with Motiva® Implants. “With the FDA approval las...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
Thu, 26.09.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round...
Read More
Establishment Labs
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S